factual

Paragon Medical deal at 12x to 13x EBITDA is the biggest risk

AMETEK paid $1.9 billion for Paragon Medical, a business generating about $150 million EBITDA (roughly 12x to 13x), up from its historical 8x to 10x, and Fakhry calls the growing scale of deals the single biggest risk to the business.

factualpending

Speaker

Nael

Evidence Quote

“To me, that is actually the single biggest risk as I think about the future of the business... they paid $1.9 billion for a business that is generating about $150 million in EBITDA. It translates to about a 12 to 13x EBITDA multiple”

Source

AMETEK: Industrial Excellence— Business Breakdowns
Created: 11/17/2026, 10:45:07 PM

Your notes

Loading notes...